Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Université Laval

$841,500.00

Identification of innate immune pathways as targets for immunomodulatory therapy in herpes simplex virus encephalitis

FY 2022-23

Summary
Infection of the brain by herpes simplex virus (HSV encephalitis) is a devastating disease associated with a mortality rate of 70% if left untreated. Even with specific antiviral therapy i.e., intravenous acyclovir, the mortality rate is still about 15% with most survivors remaining with neurological sequelae. We postulate that both virus replication in the brain and the resulting uncontrolled inflammation are responsible for such high mortality and morbidity. In the next 5 years, we will further study the types of cells responsible for the detrimental inflammation and evaluate compounds that can block the immune response in a timely manner using mouse models. In addition, we plan to set-up a more relevant experimental model for understanding the pathogenesis of HSV encephalitis using human brain 3D models derived from human stem cells (called organoids). At term, our research will benefit the management of HSV encephalitis but also potentially that of other brain viral diseases caused by West Nile virus and Zika virus.
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
478442
Name
Boivin Guy
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Identification of innate immune pathways as targets for immunomodulatory therapy in herpes simplex virus encephalitis
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$841,500
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Encephalitis; Herpes Simplex Virus; Immunomodulator; Inflammasome; Innate Immunity; Microglia; Monocytes; Mouse; Organoid; Therapy
Abstract
Infection of the brain by herpes simplex virus (HSV encephalitis) is a devastating disease associated with a mortality rate of 70% if left untreated. Even with specific antiviral therapy i.e., intravenous acyclovir, the mortality rate is still about 15% with most survivors remaining with neurological sequelae. We postulate that both virus replication in the brain and the resulting uncontrolled inflammation are responsible for such high mortality and morbidity. In the next 5 years, we will further study the types of cells responsible for the detrimental inflammation and evaluate compounds that can block the immune response in a timely manner using mouse models. In addition, we plan to set-up a more relevant experimental model for understanding the pathogenesis of HSV encephalitis using human brain 3D models derived from human stem cells (called organoids). At term, our research will benefit the management of HSV encephalitis but also potentially that of other brain viral diseases caused by West Nile virus and Zika virus.
Competitiondate
202303
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Boivin, Guy
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $841,500~ $0~
Université Laval - $841,500 Grant (2022-23) | Canada Spends